|
|
||||||||
Departments of Medicine and Physiology, Dartmouth Medical School, Lebanon, New Hampshire 03756; and Rhode Island Hospital and Brown University, Providence, Rhode Island 02903
Received 28 May 1996; accepted in final form 24 February 1996.
Colice, Gene L., Nicholas Hill, Yan-Jie Lee, Hongkai Du,
James Klinger, James C. Leiter, and Lo-Chang Ou. Exaggerated pulmonary hypertension with monocrotaline in rats susceptible to
chronic mountain sickness. J. Appl.
Physiol. 83(1): 25-31, 1997.
Hilltop (H) strain
Sprague-Dawley rats are more susceptible to chronic mountain sickness
than are the Madison (M) strain rats. It is unclear what role pulmonary
vascular remodeling, polycythemia, and hypoxia-induced vasoconstriction
play in mediating the more severe pulmonary hypertension that develops
in the H rats during chronic hypoxia. It is also unclear whether the
increased sensitivity of the H rats to chronic mountain sickness is
specific for a hypoxia effect or, instead, reflects a general
propensity toward the development of pulmonary hypertension.
Monocrotaline (MCT) causes pulmonary vascular remodeling and pulmonary
hypertension. We hypothesized that the difference in the pulmonary
vascular response to chronic hypoxia between H and M rats reflects an
increased sensitivity of the H rats to any pulmonary hypertensive
stimuli. Consequently, we expected the two strains to also differ in
their susceptibility to MCT-induced pulmonary hypertension. Pulmonary
arterial pressures in conscious H and M rats were measured 3 wk after a
single dose of MCT, exposure to a simulated high altitude of 18,000 ft
(barometric pressure = 380 mmHg), and administration of a single dose
of saline as a placebo. The H rats had significantly
higher pulmonary arterial pressures and right ventricular weights after
MCT and chronic hypoxia than did the M rats. The H rats also had more
pulmonary vascular remodeling, i.e., greater wall thickness as a
percentage of vessel diameter, after MCT and chronic hypoxia than did
the M rats. The H rats had significantly lower arterial
PO2 than did the M rats after MCT,
but the degree of hypoxemia was mild [arterial
PO2 of 72.5 ± 0.8 (SE) Torr for H
rats vs. 77.4 ± 0.8 Torr for M rats after MCT]. The H rats
had lower arterial PCO2 and larger
minute ventilation values than did the M rats after MCT. These
ventilatory differences suggest that MCT caused more severe pulmonary
vascular damage in the H rats than in the M rats. These data support
the hypothesis that the H rats have a general propensity to develop
pulmonary hypertension and suggest that differences in pulmonary
vascular remodeling account for the increased susceptibility of H rats,
compared with M rats, to both MCT and chronic hypoxia-induced pulmonary
hypertension.
chronic hypoxia; ventilation; pulmonary vascular histology
This article has been cited by other articles:
![]() |
F. Akhavein, E. J. St.-Michel, E. Seifert, and C. V. Rohlicek Decreased left ventricular function, myocarditis, and coronary arteriolar medial thickening following monocrotaline administration in adult rats J Appl Physiol, July 1, 2007; 103(1): 287 - 295. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. van Albada, R. G. Schoemaker, M. S. Kemna, A. H. Cromme-Dijkhuis, R. van Veghel, and R. M. F. Berger The role of increased pulmonary blood flow in pulmonary arterial hypertension Eur. Respir. J., September 1, 2005; 26(3): 487 - 493. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Salameh, M. R. Karamsetty, R. R. Warburton, J. R. Klinger, L. C. Ou, and N. S. Hill Differences in acute hypoxic pulmonary vasoresponsiveness between rat strains: role of endothelium J Appl Physiol, July 1, 1999; 87(1): 356 - 362. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. C. Ou, S. Salceda, S. J. Schuster, L. M. Dunnack, T. Brink-Johnsen, J. Chen, and J. C. Leiter Polycythemic responses to hypoxia: molecular and genetic mechanisms of chronic mountain sickness J Appl Physiol, April 1, 1998; 84(4): 1242 - 1251. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. QUINN, H.-K. DU, B. TAYLOR THOMPSON, and C. A. HALES Amiloride Analogs Inhibit Chronic Hypoxic Pulmonary Hypertension Am. J. Respir. Crit. Care Med., April 1, 1998; 157(4): 1263 - 1268. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |